RHYTHM PHARMACEUTICALS, INC. Quarterly Nonoperating Income (Expense) in USD from Q1 2016 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Rhythm Pharmaceuticals, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2016 to Q3 2024.
  • Rhythm Pharmaceuticals, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$100K, a 163% decline year-over-year.
  • Rhythm Pharmaceuticals, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $7.24M, a 34390% increase year-over-year.
  • Rhythm Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2023 was $243K.
  • Rhythm Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2022 was -$1.96M, a 102% decline from 2021.
  • Rhythm Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2021 was $100M, a 3795% increase from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $7.24M -$100K -$258K -163% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $7.5M $8.7M +$8.8M Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 -$1.29M -$1.19M -$1.54M -437% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $243K -$168K +$222K +56.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $21K $158K +$1.75M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 -$1.73M -$99K -$194K -204% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 -$1.54M $352K +$425K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 -$1.96M -$390K -$524K -391% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 -$1.44M -$1.59M -$1.73M -1255% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $294K $95K +$74K +352% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-01
Q1 2022 $220K -$73K -$100M -100% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q4 2021 $100M $134K -$42K -23.9% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 $100M $138K -$328K -70.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $101M $21K -$780K -97.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $102M $100M +$99M +8716% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 $2.58M $176K -$1.09M -86.1% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 $3.67M $466K -$638K -57.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 $4.31M $801K -$552K -40.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-03
Q1 2020 $4.86M $1.14M -$410K -26.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-03
Q4 2019 $5.27M $1.27M -$376K -22.9% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-02
Q3 2019 $5.65M $1.1M -$454K -29.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-02
Q2 2019 $6.1M $1.35M +$744K +122% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-03
Q1 2019 $5.36M $1.55M +$1M +185% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-04
Q4 2018 $4.35M $1.64M +$1.19M +264% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-02
Q3 2018 $3.16M $1.56M +$3.29M Jul 1, 2018 Sep 30, 2018 10-K 2020-03-02
Q2 2018 -$127K $609K +$657K Apr 1, 2018 Jun 30, 2018 10-K 2020-03-02
Q1 2018 -$784K $542K +$513K +1769% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-02
Q4 2017 -$1.3M $452K +$443K +4922% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-08
Q3 2017 -$1.74M -$1.73M -$1.74M -17400% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-08
Q2 2017 $0 -$48K -$56K -700% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-08
Q1 2017 $56K $29K +$23K +383% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-08
Q4 2016 $33K $9K Oct 1, 2016 Dec 31, 2016 8-K 2018-11-09
Q3 2016 $10K Jul 1, 2016 Sep 30, 2016 8-K 2018-11-09
Q2 2016 $8K Apr 1, 2016 Jun 30, 2016 8-K 2018-11-09
Q1 2016 $6K Jan 1, 2016 Mar 31, 2016 8-K 2018-11-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.